[PTGX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 180.15%
YoY- 187.37%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 4,675 4,167 254,953 60,000 0 0 0 -
PBT -33,630 -31,292 210,666 27,335 -34,105 -38,460 -33,725 -0.18%
Tax -420 -676 3,326 -4,242 -827 -3,913 -2,296 -67.67%
NP -33,210 -30,616 207,340 27,335 -34,105 -38,460 -31,429 3.73%
Tax Rate - - -1.58% 15.52% - - - -
Total Cost 37,885 34,783 47,613 32,665 34,105 38,460 31,429 13.22%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -710.37 -734.73 81.32 45.56 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.54 -0.50 3.41 0.45 -0.58 -0.68 -0.62 -8.77%
EPS Diluted -0.54 -0.50 3.26 0.44 -0.58 -0.68 -0.62 -8.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.